Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Gut Flora May Be Altered by Oral Semaglutide Additive

Salcaprozate sodium, the absorption-enhancing ingredient used in oral semaglutide, is associated with changes in gut microbiota and inflammatory markers in a preclinical study.

ChatGPT Excels at Classifying Ultraprocessed Foods

ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve future dietary research.

GPs ‘Reeling’ Over New Contract in England

A new GP contract for England promises same-day urgent appointments, but medical leaders warn it raises unrealistic expectations and workload risks.

Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.

GLP-1 Drugs May Raise Fracture Risk in Older Adults With T2D

GLP-1 therapy is linked to an increased risk for fragility fractures among older adults with type 2 diabetes.

Hormone Therapy Myths Hinder Bone Health in Menopause

Experts warn that misinformation about menopausal hormone therapy may be increasing fracture risk in women.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Latest News

Salcaprozate sodium, the absorption-enhancing ingredient used in oral semaglutide, is associated with changes in gut microbiota and inflammatory markers in a preclinical study.

ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve future dietary research.

A new GP contract for England promises same-day urgent appointments, but medical leaders warn it raises unrealistic expectations and workload risks.

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.

GLP-1 therapy is linked to an increased risk for fragility fractures among older adults with type 2 diabetes.

Experts warn that misinformation about menopausal hormone therapy may be increasing fracture risk in women.

News All Time

Novo Nordisk's CagriSema Trial Deals Blow in Obesity Drug Battle With Eli Lilly

Novo Nordisk's next-generation obesity drug CagriSema underperformed Eli Lilly's Zepbound in a head-to-head trial, the Danish drugmaker said on Monday, as it suffered a...

SGA Children on Growth Hormone Show Impaired Metabolism

Children born small for gestational age vs those with isolated growth hormone deficiency have impaired glucose-insulin metabolism, which worsens during growth hormone therapy.

Chan Zuckerberg Initiative Bets on Human Cell Atlas

Backed by multibillion-dollar funding, the initiative scales computing power and cell mapping to accelerate therapy discovery and immune system modelling.

Tirzepatide Now Available in Multi-Dose KwikPen

Patients who pay cash can get the multi-dose KwikPen device on LillyDirect, with prices starting at $299 for the lowest dose.

PFAS Exposure Linked to Higher Gestational Diabetes Risk

The largest meta-analysis yet conducted on the topic suggests that PFAS “forever chemicals” increase the risk for gestational diabetes, highlighting the need for exposure reduction and patient counseling.

Supportive vs Flat Flexible Shoes: No Hip OA Pain Difference

The use of stable supportive shoes does not reduce 6‑month walking hip pain in adults with chronic hip osteoarthritis more than the use of flat flexible ones, according to a randomized clinical trial.

Federal Health Data is Back Online, But Docs Still Skeptical

Information has been restored after the federal government took health information and data websites offline last year - but some physicians say their trust is shaken.

New Intervention Bests Cutting Calories for Weight Loss

Women with obesity can lose more weight with a novel multicomponent nutrition intervention called NutrirCom than on a calorie-restricted diet.

Energy Deficit and Bone Loss in Female Athletes

Social media may glamorize athletes’ diets, but restrictive eating combined with intense training can produce low energy availability, menstrual dysfunction, and bone loss in female competitors.

Why Obesity Research Is Far From Over

Clinicians warn that GLP-1 treatment often ends within a year and can lead to rapid weight regain; experts urge personalized nutrition, behavioral care, and continued research.

Digital Coaching Can Help Control Blood Glucose in T2D

A diabetes management system with personalized remote coaching can improve glycemic control to a greater extent than usual care in patients with T2D.

What Nutrients Are GLP-1 Users Lacking?

In adults with obesity and/or type 2 diabetes, GLP-1 therapy may lead to nutritional imbalances, with growing evidence indicating depletion of vitamin D, iron, and the B vitamin complex.

Distinct Viral Signature in Blood May Signal Crohn’s Disease

Researchers identify a distinct blood viral profile in Crohn’s disease, suggesting circulating bacteriophages may serve as a novel disease marker.

Gallbladder Removal Alters Resting Fat Metabolism

Cholecystectomy is associated with increased sleep energy expenditure, higher lipid oxidation, and a lower respiratory exchange ratio in Indigenous American adults.

Diabetic Retinopathy Severity Tied to Rising Dementia Risk

Greater severity of diabetic retinopathy is associated with a stepwise increase in the risk for all-cause and vascular dementia in patients with type 2 diabetes.

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Recommended News For You

'Sleep ALL night' program helps children with leukemia sleep better during treatment

An effective treatment for a rare but deadly form of cancer

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

Gene therapy for glioblastoma is effectively created by researchers.

Recommended Articles For You

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era 

Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer 

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

2.

Certain surgical gestures during prostate removal linked to better sexual function recovery

3.

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

4.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

5.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

1.

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances

2.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

3.

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management

4.

Understanding Protein C Deficiency: Symptoms, Causes, and Treatment

5.

Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

3.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

4.

Thromboprophylaxis In Medical Settings- An Update

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot